Fierro MT - Search Results

1

CD27 mRNA expression in mycosis fungoides.

Galliano I, Daprà V, Ponti R, Alliaudi C, Fierro MT, Quaglino P, Bergallo M. Galliano I, et al. Among authors: fierro mt. Ital J Dermatol Venerol. 2022 Jun;157(3):275-280. doi: 10.23736/S2784-8671.21.06953-X. Epub 2021 Jul 20. Ital J Dermatol Venerol. 2022. PMID: 34282858

2

Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.

Novelli M, Savoia P, Fierro MT, Verrone A, Quaglino P, Bernengo MG. Novelli M, et al. Among authors: fierro mt. Br J Dermatol. 1996 Jun;134(6):1052-6. Br J Dermatol. 1996. PMID: 8763423

3

Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.

Fierro MT, Doveil GC, Quaglino P, Savoia P, Verrone A, Bernengo MG. Fierro MT, et al. Dermatology. 1997;194(3):268-72. doi: 10.1159/000246116. Dermatology. 1997. PMID: 9187846

4

CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease.

Savoia P, Fierro MT, Novelli M, Quaglino P, Verrone A, Geuna M, Bernengo MG. Savoia P, et al. Among authors: fierro mt. Br J Dermatol. 1997 Dec;137(6):966-71. Br J Dermatol. 1997. PMID: 9470917

5

"Aleukemic" granulomatous leukemia cutis.

Tomasini C, Quaglino P, Novelli M, Fierro MT. Tomasini C, et al. Among authors: fierro mt. Am J Dermatopathol. 1998 Aug;20(4):417-21. doi: 10.1097/00000372-199808000-00018. Am J Dermatopathol. 1998. PMID: 9700385

6

Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features.

Bernengo MG, Quaglino P, Novelli M, Cappello N, Doveil GC, Lisa F, De Matteis A, Fierro MT, Appino A. Bernengo MG, et al. Among authors: fierro mt. Ann Oncol. 1998 Aug;9(8):857-63. doi: 10.1023/a:1008397323199. Ann Oncol. 1998. PMID: 9789608 Free article.

7

Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP.

Fierro MT, Quaglino P, Savoia P, Verrone A, Bernengo MG. Fierro MT, et al. Leuk Lymphoma. 1998 Nov;31(5-6):583-8. doi: 10.3109/10428199809057618. Leuk Lymphoma. 1998. PMID: 9922049

8

Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients.

Bernengo MG, Quaglino P, Cappello N, Lisa F, Osella-Abate S, Fierro MT. Bernengo MG, et al. Among authors: fierro mt. Melanoma Res. 2000 Feb;10(1):55-65. Melanoma Res. 2000. PMID: 10711641

9

The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.

Bernengo MG, Novelli M, Quaglino P, Lisa F, De Matteis A, Savoia P, Cappello N, Fierro MT. Bernengo MG, et al. Among authors: fierro mt. Br J Dermatol. 2001 Jan;144(1):125-35. doi: 10.1046/j.1365-2133.2001.04014.x. Br J Dermatol. 2001. PMID: 11167693

10

CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients.

Fierro MT, Novelli M, Savoia P, Cambieri I, Quaglino P, Osella-Abate S, Bernengo MG. Fierro MT, et al. J Cutan Pathol. 2001 Aug;28(7):356-62. doi: 10.1034/j.1600-0560.2001.280704.x. J Cutan Pathol. 2001. PMID: 11437941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters